Extracellular vesicles: The next generation in gene therapy delivery

Area of Science:

• Biotechnology
• Nanomedicine
• Gene Therapy

Background:

• Extracellular vesicles (EVs) are natural nanoparticles with therapeutic delivery potential.
• EVs exhibit favorable characteristics like biocompatibility, low immunogenicity, and biodegradability.
• EVs can traverse biological barriers, including the blood-brain barrier in preclinical models.

Purpose of the Study:

• To explore the potential of extracellular vesicles (EVs) as in vivo gene therapy vectors.
• To address the challenge of clinical-scale EV production for therapeutic applications.
• To propose vector transduction as a method for generating EV factories.

Main Methods:

• Reviewing current state-of-the-art EV biology and therapeutic applications.
• Extrapolating future potential based on existing knowledge.
• Proposing vector transduction technologies for ex vivo or in vivo cell modification.

Main Results:

• EVs can be engineered to carry and deliver therapeutic molecules like proteins and RNAs.
• Vector transduction offers a potential solution for scalable, safe, and stable EV production.
• This approach could enable the treatment of genetic diseases currently refractory to therapies.

Conclusions:

• Extracellular vesicles represent a promising next-generation nanodelivery tool for gene therapy.
• Vector transduction technologies can overcome clinical production challenges for EVs.
• EV-based therapies hold significant potential for treating a range of genetic disorders.